central
nervou
system
cn
viral
infect
import
caus
morbid
mortal
worldwid
systemat
survey
patient
admit
hospit
cn
infect
mani
countri
includ
indonesia
limit
obtain
inform
regard
caus
cn
infect
indonesia
studi
perform
detect
identifi
viral
agent
associ
cn
infect
amongst
inpati
referr
hospit
manado
north
sulawesi
indonesia
adult
patient
admit
rd
kandou
gener
hospit
presum
cn
infect
enrol
cerebrospin
fluid
serum
throat
swab
sampl
collect
test
use
molecular
serolog
viru
isol
assay
confirm
viral
etiolog
establish
three
probableposs
patient
common
herp
simplex
viru
follow
epsteinbarr
viru
cytomegaloviru
enteroviru
rhinoviru
dengu
viru
japanes
enceph
viru
fatal
case
hospit
eight
associ
viral
caus
identifi
herp
simplex
viru
common
caus
cn
infect
among
adult
north
sulawesi
case
remain
undiagnos
studi
highlight
challeng
establish
etiolog
viral
cn
infect
import
use
wide
rang
molecular
serolog
detect
method
identifi
cn
virus
central
nervou
system
cn
infect
includ
mening
enceph
import
caus
signific
mortal
morbid
develop
nation
virus
consid
import
etiolog
agent
cn
infect
caus
diseas
rang
febril
ill
myeliti
meningoenceph
howev
case
etiolog
cn
infect
known
due
lack
diagnost
capac
standard
clinic
case
definit
low
level
surveil
specif
diagnosi
cn
infect
rare
made
usual
categor
empir
viral
bacteri
report
viral
etiolog
cn
infect
indonesia
except
japanes
enceph
viru
jev
lead
caus
acut
enceph
children
young
adult
southeast
asian
region
still
jev
significantli
underreport
indonesia
furthermor
endem
provinc
like
bali
enceph
often
suspect
jev
lack
laboratori
capabl
accur
determin
diseas
burden
jev
cn
virus
object
studi
therefor
detect
identifi
pathogen
respons
viral
cn
infect
amongst
inpati
referr
hospit
manado
north
sulawesi
indonesia
studi
conduct
rd
kandou
gener
hospit
manado
north
sulawesi
tertiari
referr
hospit
northeastern
part
indonesia
occasion
receiv
patient
provinc
includ
central
sulawesi
north
sulawesi
north
maluku
maluku
west
papua
papua
patient
age
year
present
adult
ward
august
presum
cn
infect
enrol
base
follow
criteria
acut
onset
day
fever
alter
mental
state
accompani
seizur
focal
neurolog
find
neck
stiff
blood
andor
cerebrospin
fluid
csf
sampl
collect
along
comput
tomograph
ct
scan
without
contrast
part
assess
addit
throat
swab
also
collect
without
alter
conscious
agit
seizur
critic
ill
viral
transport
medium
contain
eagl
minimum
essenti
medium
uml
penicillin
streptomycin
fetal
bovin
serum
gibco
carlsbad
ca
specimen
store
liquid
nitrogen
requir
test
demograph
laboratori
data
includ
routin
hematolog
csf
biochemistri
data
questionnair
regard
ill
occup
anim
exposur
human
immunodefici
viru
hiv
tuberculosi
tb
statu
collect
case
record
form
enrol
andor
hospit
histori
ill
symptom
obtain
guardian
accompani
close
rel
subject
unabl
commun
csf
examin
later
flow
assay
india
ink
detect
cryptococcu
neoforman
gram
stain
detect
bacteria
direct
acidfast
bacilli
smear
examin
detect
mycobacterium
tuberculosi
addit
chest
xray
also
perform
clinic
indic
tb
limit
capac
advanc
microbiolog
test
csf
bacteri
tb
cultur
perform
onsit
undiagnos
cn
infect
patient
regardless
hiv
statu
tb
statu
csf
laboratori
result
enrol
determin
viral
caus
hivassoci
viral
infect
addit
undiagnos
cn
infect
regardless
presumpt
clinic
diagnosi
meningitisenceph
includ
studi
clinic
outcom
score
discharg
accord
glasgow
outcom
scale
go
patient
monitor
hospit
longitudin
discharg
death
integr
approach
use
molecular
serolog
viru
isol
assay
perform
retrospect
collect
specimen
eijkman
institut
molecular
biolog
jakarta
cn
infect
classifi
confirm
probabl
possibl
base
individu
pathogen
type
specimen
associ
previou
medic
condit
clinic
characterist
brief
etiolog
consid
confirm
case
posit
result
molecular
test
viru
isol
virusspecif
igm
csf
pathogen
consid
wellestablish
caus
enceph
exampl
detect
herp
simplex
cytomegaloviru
cmv
dna
csf
consid
confirmatori
etiolog
consid
probabl
pathogen
nucleic
acid
detect
csf
serolog
evid
case
pathogen
gener
caus
enceph
detect
csf
exampl
detect
antijev
igm
singl
serum
sampl
consid
probabl
etiolog
consid
possibl
case
posit
result
csf
evid
acut
infect
suggest
potenti
etiolog
role
cn
infect
exampl
detect
enterovirus
ev
pcrrtpcr
serum
throat
swab
sampl
consid
possibl
viral
nucleic
acid
extract
use
qiaamp
viral
rna
mini
kit
qiagen
hilden
germani
extract
dna
rna
procedur
conduct
accord
manufactur
instruct
elut
volum
convent
pcr
rtpcr
use
detect
alphavirus
flavivirus
filovirus
paramyxoviru
coronavirus
herpesvirus
enterovirus
use
broadli
reactiv
group
primer
pcrrtpcr
panel
cover
broad
rang
known
neurotrop
human
virus
includ
limit
chikungunya
chikv
japanes
enceph
jev
dengu
denv
west
nile
wnv
measl
mv
nipah
niv
human
coronaviru
herp
simplex
viru
cytomegaloviru
cmv
epsteinbarr
ebv
human
herpesviru
enteroviru
rhinoviru
rva
primer
previous
describ
previou
public
alphaviru
flaviviru
rtpcr
qiagen
onestep
rtpcr
qiagen
kit
use
pcr
rtpcr
goscript
revers
transcript
system
gotaq
green
master
mix
kit
use
promega
madison
wi
usa
synthet
dna
plasmid
construct
kindli
provid
predict
usaid
use
univers
posit
control
filoviru
paramyxoviru
coronaviru
herpesviru
enteroviru
pcr
describ
rna
extract
isol
jev
nakayama
strain
chikv
strain
use
flaviviru
alphaviru
rtpcr
control
respect
extract
viral
nucleic
acid
avail
csf
serum
throat
swab
amplifi
pcrrtpcr
panel
describ
posit
amplicon
purifi
sequenc
forward
revers
primer
use
big
dye
termin
readi
reaction
mix
appli
biosystem
carlsbad
ca
usa
sequenc
analys
blast
analysi
identifi
viru
speci
pcrrtpcr
assay
use
studi
design
detect
known
human
pathogen
potenti
novel
virus
facilit
use
degener
primer
multiplex
primer
andor
nest
twostep
pcr
format
sequenc
pcr
product
confirmatori
step
although
nonarbovir
group
primer
evalu
clinic
specimen
analyt
sensit
report
elsewher
addit
inhous
valid
pcrrtpcr
assay
perform
test
panel
extract
rna
serial
dilut
known
viru
isol
synthet
dna
control
panflaviviru
rtpcr
abl
detect
extract
rna
least
pfuml
pfuml
pfuml
jev
pfuml
zikv
panalphaviru
rtpcr
abl
detect
pfuml
chikv
strain
flaviviru
isol
use
evalu
panflaviviru
rtpcr
describ
elsewher
panenteroviru
rtpcr
abl
detect
least
pfuml
polioviru
sabin
vaccin
strain
copi
synthet
dna
control
panparamyxoviru
rtpcr
abl
detect
pfuml
measl
viru
vaccin
strain
copi
synthet
dna
control
final
panfiloviru
pancoronaviru
panherpesviru
pcrrtpcr
abl
detect
least
copi
copi
copi
synthet
dna
control
respect
repres
gel
electrophoresi
posit
result
pcrrtpcr
shown
fig
commerci
igm
elisa
test
kit
use
acutephas
sera
csf
detect
denvspecif
antibodi
panbio
dengu
igm
captur
elisa
aler
waltham
usa
jevspecif
antibodi
je
detect
igm
antibodi
captur
elisa
inbio
seattl
wa
usa
test
perform
interpret
follow
manufactur
recommend
csf
specimen
inocul
onto
african
green
monkey
kidney
vero
cell
previous
describ
cell
observ
daili
cytopath
effect
quantit
data
differ
two
group
compar
mannwhitney
test
categor
data
compar
use
fisher
exact
test
pvalu
less
consid
signific
total
patient
north
sulawesi
enrol
clinic
suspicion
cn
infect
studi
period
fig
detail
clinic
featur
laboratori
investig
clinic
outcom
present
tabl
fortynin
patient
male
median
age
year
rang
median
ill
day
admiss
day
rang
median
durat
hospit
stay
day
rang
median
durat
hospit
stay
rang
deceas
patient
day
rang
surviv
twentythre
patient
hivposit
tb
previou
medic
histori
patient
highgrad
fever
admiss
well
headach
alter
conscious
seizur
ct
scan
result
abnorm
patient
mostli
mening
enhanc
focal
brain
lesion
patient
respect
patient
gave
consent
lumbar
punctur
csf
avail
suffici
quantiti
viral
test
patient
serum
andor
throat
swab
fig
csf
serum
specimen
screen
two
arboviru
alphaviru
flaviviru
six
nonarboviru
degener
primer
set
two
serolog
assay
antidenv
igm
antijev
igm
addit
throat
swab
sampl
test
six
nonarboviru
panel
viral
diagnost
assay
perform
virus
identifi
summar
tabl
confirm
viral
etiolog
identifi
three
cmv
denv
probabl
possibl
associ
jev
ebv
rva
enrol
patient
twelv
case
identifi
pcrrtpcr
two
identifi
serolog
common
viral
agent
identifi
seven
patient
virus
found
ebv
n
cmv
n
n
rva
n
denv
n
jev
n
virus
isol
csf
sampl
patient
identifi
viral
infect
found
lower
gc
median
vs
p
higher
fatal
vs
p
undiagnos
tabl
studi
small
sampl
size
distinguish
clinic
laboratori
characterist
observ
differ
viral
agent
tabl
five
eight
death
associ
infect
remain
three
associ
ebv
cmv
jev
infect
one
two
ebv
case
hivposit
tb
historyposit
one
hivposit
thrombocytopenia
hallmark
dengu
fever
present
denv
case
admiss
throughout
hospit
base
serial
hematolog
examin
might
manifest
time
neurolog
present
leukocyt
count
slightli
high
admiss
well
within
normal
rang
one
week
admiss
unusu
peripher
leukocytosi
report
earlier
studi
patient
histori
fever
five
day
follow
decreas
conscious
gener
seizur
three
day
admiss
featur
dengu
fever
includ
retroorbit
pain
rash
petechia
myalgia
report
patient
surviv
mild
cognit
sequela
discharg
denv
antigen
earli
marker
denv
infect
neg
csf
use
sd
biolin
dengu
ag
rapid
test
kit
standard
diagnost
inc
south
korea
serum
test
denv
antigen
due
insuffici
volum
furthermor
panflaviviru
rtpcr
also
neg
csf
serum
sampl
fatal
jev
case
identifi
studi
neg
denv
igm
experienc
myalgia
day
accompani
highgrad
fever
seizur
alter
conscious
skin
rash
two
day
prior
hospit
csf
sampl
avail
jev
patient
attempt
isol
viru
serum
success
furthermor
two
ev
case
rva
identifi
studi
present
hospit
without
highgrad
fever
respiratori
symptom
although
case
suffer
multipl
gener
seizur
day
prior
admiss
ev
patient
discharg
without
cognit
sequela
increas
emerg
spread
neurotrop
virus
southeast
asian
western
pacif
region
howev
etiolog
cn
infect
remain
unknown
case
worldwid
numer
challeng
remain
studi
caus
cn
infect
even
resourcerich
set
mani
southeast
asian
countri
limit
laboratori
capac
indonesia
diagnos
cn
viral
infect
addit
lack
standard
laboratori
diagnost
algorithm
use
virolog
investig
inconsist
report
detect
cn
viral
infect
patient
admit
referr
hospit
manado
north
sulawesi
indonesia
use
vigor
virolog
screen
method
core
batteri
eight
group
neurotrop
virus
found
commonli
identifi
agent
cn
infect
spite
small
sampl
size
find
predominantli
identifi
viru
studi
consist
other
vietnam
india
norway
poland
studi
vietnam
thailand
report
jev
common
identifi
viral
caus
cn
infect
furthermor
recent
studi
china
itali
found
ev
primari
identifi
viral
pathogen
caus
cn
diseas
studi
case
fatal
viral
etiolog
substanti
higher
region
major
associ
highlight
signific
caus
fatal
cn
infect
indonesia
studi
two
hsv
posit
case
one
fatal
found
coexist
hiv
although
enceph
report
uncommon
hiv
patient
studi
highlight
need
diagnos
hsv
hivassoci
cn
infect
pharmacotherapi
hsv
avail
influenc
patient
outcom
definit
diagnosi
dengu
provid
detect
antidenv
igm
csf
serum
one
patient
sinc
igm
normal
cross
bloodbrain
barrier
detect
antidenv
igm
csf
indic
host
immun
respons
denv
invas
cn
absenc
denv
rna
antigen
csf
unexpect
low
sensit
rtpcr
csf
report
due
lower
viral
load
dengu
patient
studi
exhibit
shock
bleed
thrombocytopenia
patient
discharg
mild
cognit
sequela
absenc
notabl
dengu
clinic
manifest
patient
uncommon
one
studi
report
confirm
denvinfect
patient
cn
involv
characterist
featur
dengu
admiss
although
cn
manifest
rare
complic
dengu
recogn
emerg
caus
flaviviru
enceph
increas
awar
among
physician
includ
dengu
differenti
diagnosi
cn
infect
denv
could
significantli
underreport
caus
viral
infect
cn
studi
shown
outcom
dengu
enceph
variabl
patient
recov
spontan
one
case
seri
death
occur
other
one
case
posit
jev
igm
serum
without
avail
csf
diagnos
probabl
je
enceph
arboviru
antibodi
tend
persist
serum
mani
month
acut
infect
base
nationwid
seropreval
studi
je
consid
endem
indonesia
alreadi
report
present
north
sulawesi
jev
number
could
low
studi
sinc
studi
popul
consist
mainli
adult
je
neurolog
diseas
common
children
addit
convalesc
sampl
obtain
patient
determin
seroconvers
enterovirus
link
asept
mening
enceph
worldwid
two
case
ev
rva
identifi
pcr
throat
swab
known
higher
yield
csf
ev
cn
infect
viral
concentr
could
low
earli
ill
onset
panenteroviru
pcr
primer
design
detect
conserv
segment
untransl
region
ev
success
use
detect
broad
rang
ev
includ
coxsackieviru
rhinoviru
c
enteroviru
rhinoviru
echoviru
polioviru
coxsackieviru
well
number
novel
enterovirus
variou
type
clinic
sampl
detect
rate
could
low
studi
popul
adult
enteroviru
cn
infect
commonli
seen
pediatr
patient
less
adult
although
associ
mild
sever
upper
lower
respiratori
ill
studi
associ
viru
cn
diseas
furthermor
rva
consid
common
caus
upper
respiratori
tract
infect
occasion
detect
rva
cn
infect
report
rva
case
could
coexist
infect
without
suffici
evid
establish
causal
relationship
cn
infect
despit
interest
find
high
proport
case
remain
undiagnos
viral
etiolog
region
studi
could
due
time
specimen
collect
limit
viral
igm
serolog
panel
unavail
convalesc
serum
nonvir
noninfecti
caus
immunemedi
caus
infect
due
novel
pathogen
earlier
studi
shown
use
serolog
sinc
viremia
might
wane
undetect
level
time
clinic
present
sever
limit
studi
firstli
serolog
limit
arbovirus
use
hsv
igm
might
allow
case
diagnos
second
potenti
caus
viral
meningitisenceph
screen
studi
influenza
viru
rubella
viru
adenoviru
parechoviru
lymphocyt
choriomening
viru
may
miss
due
lack
test
third
incid
ev
might
underestim
studi
due
failur
collect
swab
specimen
patient
forth
ebv
cmv
may
remain
latent
b
cell
make
pcr
posit
result
difficult
interpret
fifth
mri
sensit
ct
perform
resourcelimit
healthcar
set
sixth
preval
etiolog
agent
detect
studi
might
low
compar
studi
possibl
due
differ
molecular
tool
use
panfamili
vs
virusspecif
pcrrtpcr
case
select
method
suspect
cn
infect
vs
encephalitismeningoenceph
seventh
small
sampl
size
conclus
viral
etiolog
might
statist
signific
final
csf
specimen
alway
avail
make
definit
diagnosi
viral
etiolog
patient
consent
lumbar
punctur
viral
transport
medium
throat
swab
alway
avail
howev
even
limit
rang
virus
identifi
associ
cn
diseas
eastern
indonesia
suggest
test
broader
routin
conduct
littl
done
indonesia
systemat
survey
patient
admit
hospit
cn
infect
mani
challeng
exist
determin
etiolog
viral
cn
infect
includ
time
specimen
collect
optim
storag
locat
laboratori
network
cost
test
determin
caus
cn
infect
becom
increasingli
import
emerg
new
virus
challeng
take
multipl
sampl
gener
hospit
csf
emphas
recommend
specimen
admiss
patient
present
suspect
cn
infect
followup
serum
specimen
discharg
death
serolog
confirm
result
studi
highlight
import
use
wide
rang
molecular
panel
detect
method
cn
virus
optim
treatment
strategi
guid
public
health
measur
develop
target
vaccin
recommend
howev
resourcelimit
set
highli
recommend
initi
viral
screen
includ
hsv
ev
well
flaviviru
serolog
assay
